Advertisement
BFLY vs INFU
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFLY is a Hold and INFU is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BFLY’s FA Score shows that 0 FA rating(s) are green whileINFU’s FA Score has 0 green FA rating(s).
- BFLY’s FA Score: 0 green, 5 red.
- INFU’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BFLY’s TA Score shows that 4 TA indicator(s) are bullish while INFU’s TA Score has 2 bullish TA indicator(s).
- BFLY’s TA Score: 4 bullish, 5 bearish.
- INFU’s TA Score: 2 bullish, 6 bearish.
Price Growth
BFLY (@Medical/Nursing Services) experienced а -1.58% price change this week, while INFU (@Medical/Nursing Services) price change was -6.72% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.62%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -16.57%.
Reported Earning Dates
BFLY is expected to report earnings on Jul 30, 2026.
INFU is expected to report earnings on Aug 06, 2026.
Industries' Descriptions
@Medical/Nursing Services (+7.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BFLY | INFU | BFLY / INFU | |
| Capitalization | 2.12B | 188M | 1,127% |
| EBITDA | -66.72M | 26.2M | -255% |
| Gain YTD | 113.158 | 3.679 | 3,076% |
| P/E Ratio | N/A | 25.14 | - |
| Revenue | 103M | 142M | 73% |
| Total Cash | 138M | 2.11M | 6,553% |
| Total Debt | 19.8M | 22.8M | 87% |
BFLY | INFU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 84 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 61 | |
PRICE GROWTH RATING 1..100 | 34 | 43 | |
P/E GROWTH RATING 1..100 | 100 | 83 | |
SEASONALITY SCORE 1..100 | 11 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INFU's Valuation (57) in the Medical Specialties industry is in the same range as BFLY (66) in the null industry. This means that INFU’s stock grew similarly to BFLY’s over the last 12 months.
INFU's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BFLY (100) in the null industry. This means that INFU’s stock grew similarly to BFLY’s over the last 12 months.
INFU's SMR Rating (61) in the Medical Specialties industry is somewhat better than the same rating for BFLY (98) in the null industry. This means that INFU’s stock grew somewhat faster than BFLY’s over the last 12 months.
BFLY's Price Growth Rating (34) in the null industry is in the same range as INFU (43) in the Medical Specialties industry. This means that BFLY’s stock grew similarly to INFU’s over the last 12 months.
INFU's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as BFLY (100) in the null industry. This means that INFU’s stock grew similarly to BFLY’s over the last 12 months.
| BFLY | INFU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 74% |
| Advances ODDS (%) | 15 days ago 81% | 5 days ago 64% |
| Declines ODDS (%) | 6 days ago 89% | 1 day ago 81% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 81% | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JEMA | 62.45 | N/A | N/A |
| JPMorgan ActiveBuilders EM Eq ETF | |||
| NSI | 38.14 | N/A | N/A |
| National Security Emerging Mkts Idx ETF | |||
| ZVOL | 8.33 | -0.01 | -0.12% |
| Volatility Premium Plus ETF | |||
| SIXD | 30.92 | -0.13 | -0.42% |
| AllianzIM US Equity 6M Bfr10 Jun/Dec ETF | |||
| UWM | 64.08 | -1.07 | -1.64% |
| ProShares Ultra Russell2000 | |||